Redox-Mediated Gene Therapies for Environmental Injury: Approaches and Concepts

Antioxidants and Redox Signaling

Volumn 1, Issue 1, 1999, Pages 5-27

  Engelhardt, John F ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; REACTIVE OXYGEN METABOLITE;

BIOLOGICAL MODEL; GENE THERAPY; GENE VECTOR; HUMAN; LUNG DISEASE; METABOLISM; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHYSIOLOGY; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; VASCULAR DISEASE;

ANTIOXIDANTS; GENE THERAPY; GENETIC VECTORS; HUMANS; LUNG DISEASES; MODELS, BIOLOGICAL; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; SIGNAL TRANSDUCTION; VASCULAR DISEASES;

EID: 0033086310     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.1999.1.1-5     Document Type: Review

References (159)

1. ABATE, C., PATEL, L., RAUSCHER, F.J.D., and CURRAN, T. (1990). Redox regulation of fos and jun DNA-binding activity in vitro. Science 249, 1157-1161.
2. ALEXANDER, R.W. (1998). Atherosclerosis as disease of redox-sensitive genes. Trans. Am. Clin. Climatol. Assoc. 109, 129-145.
3. ALKALAY, I., YARON, A., HATZUBAI, A., ORIAN, A., CIECHANOVER, A., and BEN-NERIAH, Y. (1995). Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA 92, 10599-10603.
4. AMALFITANO, A., HAUSER, M.A., HU, H., SERRA, D., BEGY, C.R., and CHAMBERLAIN, J.S. (1998). Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted. J. Virol. 72, 926-933.
5. AUER, K.L., CONTESSA, J., BRENZ-VERCA, S., PIROLA, L., RUSCONI, S., COOPER, G., ABO, A., WYMANN, M.P., DAVIS, R.J., BIRRER, M., and DENT, P. (1998). The Ras/Rac1/Cdc42/SEK/JNK/c-Jun cascade is a key pathway by which agonists stimulate DNA synthesis in primary cultures of rat hepatocytes. Mol. Biol. Cell 9, 561-573.
6. - in vascular smooth muscle cells. Circ. Res. 77, 29-36.
7. BARCHOWSKY, A., MUNRO, S.R., MORANA, S.J., VINCENTI, M.P., and TREADWELL, M. (1995). Oxidant-sensitive and phosphorylation-dependent activation of NF-kappa B and AP-1 in endothelial cells. Am. J. Physiol. 269, L829-L836.
8. BERLINER, J.A., and HEINECKE, J.W. (1996). The role of oxidized lipoproteins in atherogenesis. Free Radic. Biol. Med. 20, 707-727.
9. BERNARD, G.R. (1991). N-Acetylcysteine in experimental and clinical acute lung injury. Am. J. Med. 91, 54S-59S.
10. BLANN, A., MIDGLEY, H., BURROWS, G., MAXWELL, S., UTTING, S., DAVIES, M., WAITE, M., and MCCOLLUM, C. (1993). Free radicals, antioxidants, and endothelial cell damage after percutaneous transluminal coronary angioplasty. Coron. Artery Dis. 4, 905-910.
11. BLOMER, U., NALDINI, L., VERMA, I.M., TRONO, D., and GAGE, F.H. (1996). Applications of gene therapy to the CNS. Hum. Mol. Genet. 5, 1397-1404.
12. BOKOCH, G.M., and KNAUS, U.G. (1994). The role of small GTP-binding proteins in leukocyte function. Curr. Opin. Immunol. 6, 98-105.
13. BOLLI, R. (1988). Oxygen-derived free radicals and postischemic myocardial dysfunction ("stunned myocardium"). J. Am. Coll. Cardiol. 12, 239-249.
14. BORIS-LAWRIE, K., and TEMIN, H.M. (1994). The retroviral vector. Replication cycle and safety considerations for retrovirus-mediated gene therapy. Ann. N.Y. Acad. Sci. 716, 59-70; discussion 71.
15. BRIGELIUS-FLOHE, R., AUMANN, K.D., BLOCKER, H., GROSS, G., KIESS, M., KLOPPEL, K.D., MAIORINO, M., ROVERI, A., SCHUCKELT, R., USANI, F., et al. (1994). Phospholipid-hydroperoxide glutathione peroxidase. Genomic DNA, cDNA, and deduced amino acid sequence. J. Biol. Chem. 269, 7342-7348.
16. BRIGHAM, K.L., and STECENKO, A.A. (1995). Gene therapy in acute critical illness. New Horiz. 3, 321-329.
17. BRUNE, B., VON KNETHEN, A., and SANDAU, K.B. (1998). Nitric oxide and its role in apoptosis. Eur. J. Pharmacol. 351, 261-272.
18. CABLE, D.G., CACCITOLO, J.A., PEARSON, P.J., O'BRIEN, T., MULLANY, C.J., DALY, R.C., ORSZULAK, T.A., and SCHAFF, H.V. (1998). New approaches to prevention and treatment of radial artery graft vasospasm. Circulation 98, II15-21; discussion II21-22.
19. CENEVIVA, G.D., TZENG, E., HOYT, D.G., YEE, E., GALLAGHER, A., ENGELHARDT, J.F., KIM, Y.M., BILLIAR, T.R., WATKINS, S.A., and PITT, B.R. (1998). Nitric oxide inhibits lipopolysaccharide-induced apoptosis in pulmonary artery endothelial cells. Am. J. Physiol. 275, L717-728.
20. CHABOT, F., MITCHELL, J.A., GUTTERIDGE, J.M., and EVANS, T.W. (1998). Reactive oxygen species in acute lung injury. Eur. Respir. J. 11, 745-757.
21. CHANG, M.W., and LEIDEN, J.M. (1996). Gene therapy for vascular proliferative disorders. Sem. Interv. Cardiol. 1, 185-193.
22. CHANG, M.W., BARR, E., LU, M.M., BARTON, K., and LEIDEN, J.M. (1995a). Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J. Clin. Invest. 96, 2260-2268.
23. CHANG, M.W., BARR, E., SELTZER, J., JIANG, Y.Q., NABEL, G.J., NABEL, E.G., PARMACEK, M.S., and LEIDEN, J.M. (1995b). Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science 267, 518-522.
24. CHANNON, K.M., QIAN, H., NEPLIOUEVA, V., BLAZING, M.A., OLMEZ, E., SHETTY, G.A., YOUNGBLOOD, S.A., PAWLOSKI, J., MCMAHON, T., STAMLER, J.S., and GEORGE, S.E. (1998). In vivo gene transfer of nitric oxide synthase enhances vasomotor function in carotid arteries from normal and cholesterol-fed rabbits. Circulation 98, 1905-1911.
25. CHU, F.F. (1994). The human glutathione peroxidase genes GPX2, GPX3, and GPX4 map to chromosomes 14, 5, and 19, respectively. Cytogenet. Cell Genet. 66, 96-98.
26. COLLETTI, L.M., REMICK, D.G., BURTCH, G.D., KUNKEL, S.L., STRIETER, R.M., and CAMPBELL, D.A., JR. (1990). Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ichemia/reperfusion injury in the rat. J. Clin. Invest. 85, 1936-1943.
27. COLLINS, L.R., MINDEN, A., KARIN, M., and BROWN, J.H. (1996). G alpha12 stimulates c-Jun NH2-terminal kinase through the small G proteins Ras and Rac. J. Biol. Chem. 271, 17349-17353.
28. COOL, R.H., MERTEN, E., THEISS, C., and ACKER, H. (1998). Rac1, and not Rac2, is involved in the regulation of the intracellular hydrogen peroxide level in HepG2 cells. Biochem. J. 332, 5-8.
29. CRAPO, J.D., OURY, T., RABOUILLE, C., SLOT, J.W., and CHANG, L.Y. (1992). Copper, zinc superoxide dismutase is primarily a cytosolic protein in human cells. Proc. Natl. Acad. Sci. USA 89, 10405-10409.
30. CRISTIANO, R.J., SMITH, L.C., KAY, M.A., BRINKLEY, B.R., and WOO, S.L. (1993). Hepatic gene therapy: Efficient gene delivery and expression in primary hepatocytes utilizing a conjugated adenovirus-DNA complex. Proc. Natl. Acad. Sci. USA 90, 11548-11552.
31. CURIEL, D.T., PILEWSKI, J.M., and ALBELDA, S.M. (1996). Gene therapy approaches for inherited and acquired lung diseases. Am. J. Respir. Cell. Mol. Biol. 14, 1-18.
32. DANEL, C., ERZURUM, S.C., PRAYSSAC, P., EISSA, N.T., CRYSTAL, R.G., HERVE, P., BAUDET, B., MAZMANIAN, M., and LEMARCHAND, P. (1998). Gene therapy for oxidant injury-related diseases: Adenovirus-mediated transfer of superoxide dismutase and catalase cDNAs protects against hyperoxia but not against ischemia-reperfusion lung injury. Hum. Gene Ther. 9, 1487-1496.
33. DONG, J.Y., FAN, P.D., and FRIZZELL, R.A. (1996). Quantitative analysis of the packaging capacity of recombinant adeno-associated virus. Hum. Gene Ther. 7, 2101-2112.
34. DUAN, D., SHARMA, P., YANG, J., YUE, Y., DUDUS, L., ZHANG, Y., FISHER, K.J., and ENGELHARDT, J.F. (1998). Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long term episomal persistence in muscle. J. Virol. 72, 8568-8577.
35. DUFAURE, J.P., LAREYRE, J.J., SCHWAAB, V., MATTEI, M.G., and DREVET, J.R. (1996). Structural organization, chromosomal localization, expression and phylogenetic evaluation of mouse glutathione peroxidase encoding genes. C.R. Acad. Sci. III 319, 559-568.
36. DUSTING, G.J. (1996). Nitric oxide in coronary artery disease: roles in atherosclerosis, myocardial reperfusion and heart failure. Exs 76, 33-55.
37. ENGELHARDT, J.F. (1996). Methods of adenoviral-mediated gene transfer to airway epithelium in methods in molecular biology. In Gene Therapy Protocols. (Humana Press, Inc., Totowa, NJ) pp. 169-184.
38. ENGELHARDT, J.F., YE, X., DORANZ, B., and WILSON, J.M. (1994). Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA 91, 6196-6200.
39. EPPERLY, M., BRAY, J., KRAEGER, S., ZWACKA, R., ENGELHARDT, J., TRAVIS, E., and GREENBERGER, J. (1998). Prevention of late effects of irradiation lung damage by manganese superoxide dismutase gene therapy. Gene Ther. 5, 196-208.
40. ERZURUM, S.C., LEMARCHAND, P., ROSENFELD, M.A., YOO, J.H., and CRYSTAL, R.G. (1993). Protection of human endothelial cells from oxidant injury by adenovirus-mediated transfer of the human catalase cDNA. Nucleic Acids Res. 21, 1607-1612.
41. FANG, S., SHARMA, R.V., and BHALLA, R.C. (1999). Enhanced recovery of injury caused downregulation of paxillin protein by eNOS gene expression in rat carotid artery: Mechanism of NO inhibition of intimal hyperplasia? [In Process Citation]. Arterioscler. Thromb. Vasc. Biol. 19, 147-152.
42. FANG, X., WEINTRAUB, N.L., RIOS, C.D., CHAPPELL, D.A., ZWACKA, R.M., ENGELHARDT, J.F., OBERLEY, L.W., YAN, T., HEISTAD, D.D., and SPECTOR, A.A. (1998). Overexpression of human superoxide dismutase inhibits oxidation of low-density lipoprotein by endothelial cells. Circ. Res. 82, 1289-1297.
43. FERRAN, C., MILLAN, M.T., CSIZMADIA, V., COOPER, J.T., BROSTJAN, C., BACH, F.H., and WINKLER, H. (1995). Inhibition of NF-kappa B by pyrrolidine dithiocarbamate blocks endothelial cell activation. Biochem. Biophys. Res. Commun. 214, 212-223.
44. FISHER, K.J., and WILSON, J.M. (1994). Biochemical and functional analysis of an adenovirus-based ligand complex for gene transfer. Biochem. J. 299, 49-58.
45. FLAHERTY, J.T., and WEISFELDT, M.L. (1988). Reperfusion injury. Free Radic. Biol. Med. 5, 409-419.
46. FLOHE, L., BRIGELIUS-FLOHE, R., SALIOU, C., TRABER, M.G., and PACKER, L. (1997). Redox regulation of NF-kappa B activation. Free Radic. Biol. Med. 22, 1115-1126.
47. FLOTTE, T.R., and CARTER, B.J. (1995). Adeno-associated virus vectors for gene therapy. Gene Ther. 2, 357-362.
48. FLOTTE, T.R., AFIONE, S.A., and ZEITLIN, P.L. (1994). Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration. Am. J. Respir. Cell. Mol. Biol. 11, 517-521.
49. FORMAN, M.B., VIRMANI, R., and PUETT, D.W. (1990). Mechanisms and therapy of myocardial reperfusion injury. Circulation 81, IV69-78.
50. FRIEDMANN, T., and YEE, J.K. (1995). Pseudotyped retroviral vectors for studies of human gene therapy. Nature Med. 1, 275-277.
51. GAO, G.P., QU, G., FAUST, L.Z., ENGDAHL, R.K., XIAO, W., HUGHES, J.V., ZOLTICK, P.W., and WILSON, J.M. (1998). High-titer adeno-associated viral vectors from a Rep/Cap cell line and hybrid shuttle virus. Hum. Gene Ther. 9, 2353-2362.
52. GERGEL, D., MISIK, V., RIESZ, P., and CEDERBAUM, A.I. (1997). Inhibition of rat and human cytochrome P4502E1 catalytic activity and reactive oxygen radical formation by nitric oxide. Arch. Biochem. Biophys. 337, 239-250.
53. GILLISSEN, A., and NOWAK, D. (1998). Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy. Respir. Med. 92, 609-623.
54. GOLDSTONE, S.D., and HUNT, N.H. (1997). Redox regulation of the mitogen-activated protein kinase pathway during lymphocyte activation. Biochim. Biophys. Acta 1355, 353-360.
55. GONZALEZ-ZULUETA, M., ENSZ, L.M., MUKHINA, G., LEBOVITZ, R.M., ZWACKA, R.M., ENGELHARDT, J.F., OBERLEY, L.W., DAWSON, V.L., and DAWSON, T.M. (1998). Manganese superoxide dismutase protects nNOS neurons from NMDA and nitric oxide-mediated neurotoxicity. J. Neurosoci. 18, 2040-2055.
56. GRAHAM, F.L., and PREVEC, L. (1995). Methods for construction of adenovirus vectors. Mol. Biotechnol. 3, 207-220.
57. GRIENDLING, K.K., and USHIO-FUKAI, M. (1998). Redox control of vascular smooth muscle proliferation. J. Lab. Clin. Med. 132, 9-15.
58. GRIENDLING, K.K., MINIERI, C.A., OLLERENSHAW, J.D., and ALEXANDER, R.W. (1994). Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 74, 1141-1148.
59. GULBINS, E., BRENNER, B., SCHLOTTMANN, K., WELSCH, J., HEINLE, H., KOPPENHOEFER, U., LINDERKAMP, O., COGGESHALL, K.M., and LANG, F. (1996). Fas-induced programmed cell death is mediated by a Ras-regulated O2-synthesis. Immunology 89, 205-212.
60. HAMBLETON, J., WEINSTEIN, S.L., LEM, L., and DEFRANCO, A.L. (1996). Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proc. Natl. Acad. Sci. USA 93, 2774-2778.
61. HARRISON, D.G. (1997). Endothelial function and oxidant stress. Clin. Cardiol. 20, II-11-17.
62. HIROTA, K., MATSUI, M., IWATA, S., NISHIYAMA, A., MORI, K., and YODOI, J. (1997). AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc. Natl. Acad. Sci. USA 94, 3633-3638.
63. HJALMARSSON, K., MARKLUND, S.L., ENGSTROM, A., and EDLUND. T. (1987). Isolation and sequence of complementary DNA encoding human extracellular superoxide dismutase. Proc. Natl. Acad. Sci. USA 84, 6340-6344.
64. HO, Y.S., and CRAPO, J.D. (1988). Isolation and characterization of complementary DNAs encoding human manganese-containing superoxide dismutase. FEBS Lett. 229, 256-260.
65. IMBERT, V., RUPEC, R.A., LIVOLSI, A., PAHL, H.L., TRAENCKNER, E.B., MUELLER-DIECKMANN, C., FARAHIFAR, D., ROSSI, B., AUBERGER, P., BAEUERLE, P.A., and PEYRON, J.F. (1996). Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha. Cell 86, 787-798.
66. JACOBS, M.D., and HARRISON, S.C. (1998). Structure of an IkappaBalpha/NF-kappaB complex. Cell 95, 749-758.
67. JAYARAMAN, L., MURTHY, K.G., ZHU, C., CURRAN, T., XANTHOUDAKIS, S., and PRIVES, C. (1997). Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes & Dev. 11, 558-570.
68. JOBIN, C., PANJA, A., HELLERBRAND, C., IIMURO, Y., DIDONATO, J., BRENNER, D.A., and SARTOR, R.B. (1998). Inhibition of proinflammatory molecule production by adenovirus-mediated expression of a nuclear factor kappaB super-repressor in human intestinal epithelial cells. J. Immunol. 160, 410-418.
69. JUURLINK, B.H., and SWEENEY, M.I. (1997). Mechanisms that result in damage during and following cerebral ischemia. Neurosci. Biobehav. Rev. 21, 121-128.
70. KARIN, M., LIU, Z., and ZANDI, E. (1997). AP-1 function and regulation. Curr. Opin. Cell. Biol. 9, 240-246.
71. KIM, K.S., TAKEDA, K., SETHI, R., PRACYK, J.B., TANAKA, K., ZHOU, Y.F., YU, Z.X., FERRANS, V.J., BRUDER, J.T., KOVESDI, I., IRANI, K., GOLDSCHMIDT-CLERMONT, P., and FINKEL, T. (1998). Protection from reoxygenation injury by inhibition of rac1. J. Clin. Invest. 101, 1821-1826.
72. KOMADA, F., NISHIGUCHI, K., TANIGAWARA, Y., AKAMATSU, T., WU, X.Y., IWAKAWA, S., and OKUMURA, K. (1996). Effect of transfection with superoxide dismutase expression plasmid on superoxide anion induced cytotoxicity in cultured rat lung cells. Biol. Pharm. Bull. 19, 274-279.
73. KRETZ-REMY, C., MEHLEN, P., MIRAULT, M.E., and ARRIGO, A.P. (1996). Inhibition of I kappa B-alpha phosphorylation and degradation and subsequent NF-kappa B activation by glutathione peroxidase overexpression. J. Cel Biol. 133, 1083-1093.
74. KUMAR-SINGH, R., and CHAMBERLAIN, J.S. (1996). Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells. Hum. Mol. Genet. 5, 913-921.
75. LANDMANN, R., SCHERER, F., SCHUMANN, R., LINK, S., SANSANO, S., and ZIMMERLI, W. (1995). LPS directly induces oxygen radical production in human monocytes via LPS binding protein and CD14. J. Leukoc. Biol. 57, 440-449.
76. LARRICK, J.W., and WRIGHT, S.C. (1990). Cytotoxic mechanism of tumor necrosis factor-alpha. FASEB J. 4, 3215-3223.
77. LI, Q., BOLLI, R., QIU, Y., TANG, X.L., MURPHREE, S.S., and FRENCH, B.A. (1998). Gene therapy with extracellular superoxide dismutase attenuates myocardial stunning in conscious rabbits. Circulation 98, 1438-1448.
78. LIAO, F., ANDALIBI, A., QIAO, J.H., ALLAYEE, H., FOGELMAN, A.M., and LUSIS, A.J. (1994). Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice. J. Clin. Invest. 94, 877-884.
79. LIMURO, Y., NISHIURA, T., HELLERBRAND, C., BEHRNS, K.E., SCHOONHOVEN, R., GRISHAM, J.W., and BRENNER, D.A. (1998). NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. J. Clin. Invest. 101, 802-811.
80. LIOU, W., CHANG, L.Y., GEUZE, H.J., STROUS, G.J., CRAPO, J.D., and SLOT, J.W. (1993). Distribution of CuZn superoxide dismutase in rat liver. Free Radic. Biol. Med. 14, 201-207.
81. LO, Y.Y., and CRUZ, T.F. (1995). Involvement of reactive oxygen species in cytokine and growth factor induction of c-fos expression in chondrocytes. J. Biol. Chem. 270, 11727-11730.
82. LO, Y.Y.C., WONG, J.M.S., and CRUZ, T.F. (1996). Reactive oxygen species mediate cytokine activation of c-Jun NH2-terminal kinases. J. Biol. Chem. 271, 15703-15707.
83. MARUBAYASHI, S., and DOHI, K. (1996). Therapeutic modulation of free radical-mediated reperfusion injury of the liver and its surgical implications. Surg. Today 26, 573-580.
84. MCCORD, J.M. (1985). Oxygen-derived free radicals in postischemic tissue injury. N. Engl. J. Med. 312, 159-163.
85. MCLAUGHLIN, S.K., COLLIS, P., HERMONAT, P.L., and MUZYCZKA, N. (1988). Adeno-associated virus general transduction vectors: analysis of proviral structures. J. Virol. 62, 1963-1973.
86. MEIER, B., RADEKE, H.H., SELLE, S., YOUNES, M., SIES, H., RESCH, K., and HABERMEHL, G.G. (1989). Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-alpha. Biochem. J. 263, 539-545.
87. MEISTER, A. (1988). Glutathione metabolism and its selective modification. J. Biol. Chem. 263, 17205-17208.
88. MERCURIO, F., ZHU, H., MURRAY, B.W., SHEVCHENKO, A., BENNETT, B.L., LI, J., YOUNG, D.B., BARBOSA, M., MANN, M., MANNING, A., and RAO, A. (1997). IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation [see comments]. Science 278, 860-866.
89. 2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 12, 2005-2015.
90. MEYER, M., PAHL, H.L., and BAEUERLE, P.A. (1994). Regulation of the transcription factors NF-kappa B and AP-1 by redox changes. Chem. Biol. Interact. 91, 91-100.
91. MIAO, C.H., SNYDER, R.O., SCHOWALTER, B.D., PATIJN, G.A., DONAHUE, B., WINTHER, B., and KAY, M.A. (1998). The kinetics of rAAV integration in the liver [letter]. Nature Genet. 19, 13-15.
92. MITOMO, K., NAKAYAMA, K., FUJIMOTO, K., SUN, X., SEKI, S., and YAMAMOTO, K. (1994). Two different cellular redox systems regulated the DNA-binding activity of the p50 subunit of NF-kappa B in vitro. Gene 145, 197-203.
93. MIZOE, A., KONDO, S., AZUMA, T., FUJIOKA, H., TANAKA, K., HASHIDA, M., and KANEMATSU, T. (1997). Preventive effects of superoxide dismutase derivatives modified with monosaccharides on reperfusion injury in rat liver transplantation. J. Surg. Res. 73, 160-165.
94. MURPHY, K., HAUDEK, S.B., THOMPSON, M., and GIROIR, B.P. (1998). Molecular biology of septic shock. New Horiz. 6, 181-193.
95. MUSE, K.E., OBERLEY, T.D., SEMPF, J.M., and OBERLEY, L.W. (1994). Immunolocalization of antioxidant enzymes in adult hamster kidney. Histochem. J. 26, 734-753.
96. MYERS, M.L., and FREMES, S.E. (1996). Myocardial protection for cardiac surgery. Exs 76, 345-364.
97. NAKAMURA, H., NAKAMURA, K., and YODOI, J. (1997). Redox regulation of cellular activation. Annu. Rev. Immunol. 15, 351-369.
98. NALDINI, L., BLOMER, U., GALLAY, P., ORY, D., MULLIGAN, R., GAGE, F.H., VERMA, I.M., and TRONO, D. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector [see comments]. Science 272, 263-267.
99. NATOLI, G., COSTANZO, A., IANNI, A., TEMPLETON, D.J., WOODGETT, J.R., BALSANO, C., and LEVRERO, M. (1997). Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science 275, 200-203.
100. NAUMANN, M., and SCHEIDEREIT, C. (1994). Activation of NF-kappa B in vivo is regulated by multiple phosphorylations. EMBO J. 13, 4597-4607.
101. NISHIGUCHI, K., ISHIDA, K., NAKAJIMA, M., MAEDA, T., KOMADA, F., IWAKAWA, S., TANIGAWARA, Y., and OKUMURA, K. (1996). Effects of transfection with the Cu, Zn-superoxide dismutase gene on xanthine/ xanthine oxidase-induced cytotoxicity in fibroblasts from rat skin. Pharm. Res. 13, 577-582.
102. O'NEAL, W.K., ZHOU, H., MORRAL, N., AGUILAR-CORDOVA, E., PESTANER, J., LANGSTON, C., MULL, B., WANG, Y., BEAUDET, A.L., and LEE, B. (1998). Toxicological comparison of E2a-deleted and first-generation adenoviral vectors expressing alpha1-antitrypsin after systemic delivery. Hum. Gene Ther. 9, 1587-1598.
103. ONOUE, H., TSUTSUI, M., SMITH, L., STELTER, A., O'BRIEN, T., and KATUSIC, Z.S. (1998). Expression and function of recombinant endothelial nitric oxide synthase gene in canine basilar artery after experimental subarachnoid hemorrhage. Stroke 29, 1959-1965; discussion 1965-1966.
104. OOBOSHI, H., TOYODA, K., FARACI, F.M., LANG, M.G., and HEISTAD, D.D. (1998). Improvement of relaxation in an atherosclerotic artery by gene transfer of endothelial nitric oxide synthase. Arterioscler. Thromb. Vasc. Biol. 18, 1752-1758.
105. PARKS, D.A., BULKLEY, G.B., and GRANGER, D.N. (1983). Role of oxygen free radicals in shock, ischemia, and organ preservation. Surgery 94, 428-432.
106. PHAN, S.H., GANNON, D.E., VARANI, J., RYAN, U.S., and WARD, P.A. (1989). Xanthine oxidase activity in rat pulmonary artery endothelial cells and its alteration by activated neutrophils. Am. J. Pathol. 134, 1201-1211.
107. PHILLIPS, S.C. (1995). Receptor-mediated DNA delivery approaches to human gene therapy. Biologicals 23, 13-16.
108. PHILLIS, J.W. (1994). A "radical" view of cerebral ischemic injury. Prog. Neurobiol. 42, 441-448.
109. PIETTE, J., PIRET, B., BONIZZI, G., SCHOONBROODT, S., MERVILLE, M.P., LEGRAND-POELS, S., and BOURS, V. (1997). Multiple redox regulation in NF-kappaB transcription factor activation. Biol. Chem. 378, 1237-1245.
110. POLI, G., CUTRIN, J.C., and BIASI, F. (1998). Lipid peroxidation in the reperfusion injury of the liver. Free Radic. Res. 28, 547-551.
111. PURI, P.L., AVANTAGGIATI, M.L., BURGIO, V.L., CHIRILLO, P., COLLEPARDO, D., NATOLI, G., BALSANO, C., and LEVRERO, M. (1995). Reactive oxygen intermediates mediate angiotensin II-induced c-Jun.c-Fos heterodimer DNA binding activity and proliferative hypertrophic responses in myogenic cells. J. Biol. Chem. 270, 22129-22134.
112. QUAN, F., KORNELUK, R.G., TROPAK, M.B., and GRAVEL, R.A. (1986). Isolation and characterization of the human catalase gene. Nucleic Acids Res. 14, 5321-5325.
113. RAO, G.N., and BERK, B.C. (1992). Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ. Res. 70, 593-599.
114. RAO, G.N., LASSEGUE, B., GRIENDLING, K.K., and ALEXANDER, R.W. (1993). Hydrogen peroxide stimulates transcription of c-jun in vascular smooth muscle cells: role of arachidonic acid. Oncogene 8, 2759-2764.
115. REMICK, D.G. (1995). Applied molecular biology of sepsis. J. Crit. Care 10, 198-212.
116. RICHTER, J., GULLBERG, U., and LANTZ, M. (1995). TNF-induced superoxide anion production in adherent human neutrophils involves both the p55 and p75 TNF receptor. J. Immunol. 154, 4142-4149.
117. ROBERTS, M.L., and COWSERT, L.M. (1998). Interleukin-1 beta and reactive oxygen species mediate activation of c-Jun NH2-terminal kinases, in human epithelial cells, by two independent pathways. Biochem. Biophys. Res. Commun. 251, 166-172.
118. RUSSELL, D.W., and HIRATA, R.K. (1998). Human gene targeting by viral vectors [see comments]. Nature Gent. 18, 325-330.
119. SALMONS, B., SALLER, R.M., BAUMANN, J.G., and GUNZBURG, W.H. (1995). Construction of retroviral vectors for targeted delivery and expression of therapeutic genes. Leukemia 9(Suppl 1), S53-60.
120. SAMULSKI, R.J. (1993). Adeno-associated virus: Integration at a specific chromosomal locus. Curr. Opin. Genet. Dev. 3, 74-80.
121. SATO, M., MIYAZAKI, T., NAGAYA, T., MURATA, Y., IDA, N., MAEDA, K., and SEO, H. (1996). Antioxidants inhibit tumor necrosis factor-alpha mediated stimulation of interleukin-8, monocyte chemoattractant protein-1, and collagenase expression in cultured human synovial cells. J. Rheumatol. 23, 432-438.
122. SATRIANO, J., and SCHLONDORFF, D. (1994). Activation and attenuation of transcription factor NF-kB in mouse glomerular mesangial cells in response to tumor necrosis factor-alpha, immunoglobulin G, and adenosine 3′:5′-cyclic monophosphate. Evidence for involvement of reactive oxygen species. J. Clin. Invest. 94, 1629-1636.
123. SCHERER, D.C., BROCKMAN, J.A., CHEN, Z., MANIATIS, T., and BALLARD, D.W. (1995). Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination. Proc. Natl. Acad. Sci. USA 92, 11259-11263.
124. SCHIEDNER, G., MORRAL, N., PARKS, R.J., WU, Y., KOOPMANS, S.C., LANGSTON, C., GRAHAM, F.L., BEAUDET, A.L., and KOCHANEK, S. (1998). Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity [published erratum appears in Nature Genet. 1998 Mar; 18(3):298]. Nature Genet. 18, 180-183.
125. SCHNEEBERGER, H., SCHLEIBNER, S., SCHILLING, M., ILLNER, W.D., ABENDROTH, D., HANCKE, E., JANICKE, U., and LAND, W. (1990). Prevention of acute renal failure after kidney transplantation by treatment with rh-SOD: interim analysis of a double-blind placebo-controlled trial. Transplant. Proc. 22, 2224-2225.
126. SCHRECK, R., RIEBER, P., and BAEUERLE, P.A. (1991). Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 10, 2247-2258.
127. SHEARS, L.L., 2nd, KIBBE, M.R., MURDOCK, A.D., BILLIAR, T.R., LIZONOVA, A., KOVESDI, I., WATKINS, S.C., and TZENG, E. (1998). Efficient inhibition of intimal hyperplasia by adenovirus-mediated inducible nitric oxide synthase gene transfer to rats and pigs in vivo. J. Am. Coll. Surg. 187, 295-306.
128. SHERMAN, L., DAFNI, N., LIEMAN-HURWITZ, J., and GRONER, Y. (1983). Nucleotide sequence and expression of human chromosome 21-encoded superoxide dismutase mRNA. Proc. Natl. Acad. Sci. USA 80, 5465-5469.
129. SIMPSON, P.J., and LUCCHESI, B.R. (1987). Free radicals and myocardial ischemia and reperfusion injury. J. Lab. Clin. Med. 110, 13-30.
130. SULCINER, D.J., IRANI, K., YU, Z.X., FERRANS, V.J., GOLDSCHMIDT-CLERMONT, P., and FINKEL, T. (1996). rac1 regulates a cytokine-stimulated, redox-dependent pathway necessary for NF-kappaB activation. Mol. Cell. Biol. 16, 7115-7121.
131. SUNDARESAN, M., YU, Z.X., FERRANS, V.J., SULCINER, D.J., GUTKIND, J.S., IRANI, K., GOLDSCHMIDT-CLERMONT, P.J., and FINKEL, T. (1996). Regulation of reactive-oxygen-species generation in fibroblasts by Rac1. Biochem. J. 318, 379-382.
132. SWEENEY, M.I., YAGER, J.Y., WALZ, W., and JUURLINK, B.H. (1995). Cellular mechanisms involved in brain ischemia. Can. J. Physiol. Pharmacol. 73, 1525-1535.
133. TANG, G., WHITE, J.E., GORDON, R.J., LUMB, P.D., and TSAN, M.F. (1993). Polyethylene glycol-conjugated superoxide dismutase protects rats against oxygen toxicity. J. Appl. Physiol. 74, 1425-1431.
134. TAO, J., SANGHERA, J.S., PELECH, S.L., WONG, G., and LEVY, J.G. (1996). Stimulation of stress-activated protein kinase and p38 HOG1 kinase in murine keratinocytes following photodynamic therapy with benzoporphyrin derivative. J. Biol. Chem. 271, 27107-27115.
135. TAYLOR, D.E., and PIANTADOSI, C.A. (1995). Oxidative metabolism in sepsis and sepsis syndrome. J. Crit. Care 10, 122-135.
136. TOBOREK, M., BARGER, S.W., MATTSON, M.P., MCCLAIN, C.J., and HENNIG, B. (1995). Role of glutathione redox cycle in TNF-alpha-mediated endothelial cell dysfunction. Atherosclerosis 117, 179-188.
137. TURRENS, J.F., CRAPO, J.D., and FREEMAN, B.A. (1984). Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase. J. Clin. Invest. 73, 87-95.
138. TZENG, E., BILLIAR, T.R., WILLIAMS, D.L., LI, J., LIZONOVA, A., KOVESDI, I., and KIM, Y.M. (1998). Adenovirus-mediated inducible nitric oxide synthase gene transfer inhibits hepatocyte apoptosis. Surgery 124, 278-283.
139. USHIO-FUKAI, M., ZAFARI, A.M., FUKUI, T., ISHIZAKA, N., and GRIENDLING, K.K. (1996). p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J. Biol. Chem. 271, 23317-23321.
140. USHIO-FUKAI, M., ALEXANDER, R.W., AKERS, M., and GRIENDLING, K.K. (1998). p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J. Biol. Chem. 273, 15022-15029.
141. UTSUNOMIYA, H., KOMATSU, N., YOSHIMURA, S., TSUTSUMI, Y., and WATANABE, K. (1991). Exact ultrastructural localization of glutathione peroxidase in normal rat hepatocytes: advantages of microwave fixation. J. Histochem. Cytochem. 39, 1167-1174.
142. VARENNE, O., PISLARU, S., GILLIJNS, H., VAN PELT, N., GERARD, R.D., ZOLDHELYI, P., VAN DE WERF, F., COLLEN, D., and JANSSENS, S.P. (1998). Local adenovirus-mediated transfer of human endothelial nitric oxide synthase reduces luminal narrowing after coronary angioplasty in pigs. Circulation 98, 919-926.
143. WALTHER, F.J., DAVID-CU, R., and LOPEZ, S.L. (1995). Antioxidant-surfactant liposomes mitigate hyperoxic lung injury in premature rabbits. Am. J. Physiol. 269, L613-L617.
144. WANG, P., CHEN, H., QIN, H., SANKARAPANDI, S., BECHER, M.W., WONG, P.C., and ZWEIER, J.L. (1998). Overexpression of human copper, zinc-superoxide dismutase (SOD1) prevents postischemic injury. Proc. Natl. Acad. Sci. USA 95, 4556-1560.
145. WHITE, C.W., AVRAHAM, K.B., SHANLEY, P.F., and GRONER, Y. (1991). Transgenic mice with expression of elevated levels of copper-zinc superoxide dismutase in the lungs are resistant to pulmonary oxygen toxicity. J. Clin. Invest. 87, 2162-2168.
146. WISPE, J.R., WARNER, B.B., CLARK, J.C., DEY, C.R., NEUMAN, J., GLASSER, S.W., CRAPO, J.D., CHANG, L.Y., and WHITSETT, J.A. (1992). Human Mn-superoxide dismutase in pulmonary epithelial cells of transgenic mice confers protection from oxygen injury. J. Biol. Chem. 267, 23937-23941.
147. WONG, G.H., ELWELL, J.H., OBERLEY, L.W., and GOEDDEL, D.V. (1989). Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 58, 923-931.
148. XANTHOUDAKIS, S., MIAO, G., WANG, F., PAN, Y.C., and CURRAN, T. (1992). Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. EMBO J. 11, 3323-3335.
149. YAMASAKI, K., EDINGTON, H.D., MCCLOSKY, C., TZENG, E., LIZONOVA, A., KOVESDI, I., STEED, D.L., and BILLIAR, T.R. (1998). Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer. J. Clin. Invest. 101, 967-971.
150. YANG, Y., NUNES, F.A., BERENCSI, K., FURTH, E.E., GONCZOL, E., and WILSON, J.M. (1994). Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91, 4407-4411.
151. YANG, Y., GREENOUGH, K., and WILSON, J.M. (1996a). Transient immune blockade prevents formation of neutralizing antibody to recombinant adenovirus and allows repeated gene transfer to mouse liver. Gene Ther. 3, 412-420.
152. YANG, Y., SU, Q., GREWAL, I.S., SCHILZ, R., FLAVELL, R.A., and WILSON, J.M. (1996b). Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissues. J. Virol. 70, 6370-6377.
153. YAO, K.S., CLAYTON, M., and O'DWYER, P.J. (1995). Apoptosis in human adenocarcinoma HT29 cells induced by exposure to hypoxia. J. Natl. Cancer Inst. 87, 117-122.
154. YATES, M.T., LAMBERT, L.E., WHITTEN, J.P., MCDONALD, I., MANO, M., KU, G., and MAO, S.J. (1992). A protective role for nitric oxide in the oxidative modification of low density lipoproteins by mouse macrophages. FEBS Lett. 309, 135-138.
155. YEE, J.K., FRIEDMANN, T., and BURNS, J.C. (1994). Generation of high-titer pseudotyped retroviral vectors with very broad host range. Methods Cell Biol. 43, 99-112.
156. ZATLOUKAL, K., SCHMIDT, W., COTTEN, M., WAGNER, E., STINGL, G., and BIRNSTIEL, M.L. (1993). Somatic gene therapy for cancer: the utility of transfer-infection in generating 'tumor vaccines'. Gene 135, 199-207.
157. ZWACKA, R.M., DUDUS, L., EPPERLY, M.W., GREENBERGER, J.S., and ENGELHARDT, J.F. (1998a). Redox gene therapy protects human IB-3 lung epithelial cells against ionizing radiation-induced apoptosis. Hum. Gene. Ther. 9, 1381-1386.
158. ZWACKA, R.M., ZHANG, Y., ZHOU, W., HALLDORSON, J., and ENGELHARDT, J.F. (1998b). Ischemia/ reperfusion injury in the liver of BALB/c mice activates AP-1 and nuclear factor kappaB independently or IkappaB degradation. Hepatology 28, 1022-1030.
159. ZWACKA, R.M., ZHOU, W., ZHANG, Y., DARBY, C.J., DUDUS, L., HALLDORSON, J., OBERLEY, L., and ENGELHARDT, J.F. (1998c). Redox gene therapy for ischemia/reperfusion injury of the liver reduces AP1 and NF-kappaB activation. Nature Med. 4, 698-704.